Lung CCR6(−)CXCR3(−) type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases

Progressive fibrosing interstitial lung diseases (PF-ILDs) have a poor prognosis and may be resistant to corticosteroids and/or immunosuppressants, but antifibrotic therapies such as nintedanib and pirfenidone have been shown to slow the deterioration of lung function. The aim of this study was to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukuda, Tsukie Kin, Ohnishi, Hiroshi, Fujimoto, Minoru, Nakatani, Yu, Takamatsu, Kazufumi, Naka, Tetsuji, Yokoyama, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666512/
https://www.ncbi.nlm.nih.gov/pubmed/36380088
http://dx.doi.org/10.1038/s41598-022-24011-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666512/
https://www.ncbi.nlm.nih.gov/pubmed/36380088
http://dx.doi.org/10.1038/s41598-022-24011-0

Ejemplares similares